(Q51900419)

17 April 2018

title

Residual infectious disease risk in screened blood transfusion from a high-prevalence population: Santa Catarina, Brazil. (English)

1 reference

17 April 2018

0 references

1 reference

2

1 reference

17 April 2018

Adrian C. Sleigh

series ordinal

4

1 reference

17 April 2018

author name string

Christina Maresch

series ordinal

1

1 reference

17 April 2018

Andrew D Wilson

series ordinal

3

1 reference

17 April 2018

publication date

13 November 2007

1 reference

17 April 2018

published in

Transfusion

1 reference

17 April 2018

volume

48

1 reference

17 April 2018

issue

2

1 reference

17 April 2018

page(s)

273-281

1 reference

17 April 2018

Safety of the blood supply in Latin America

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01521.X

Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01521.X

The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01521.X

Current impact of the confidential unit exclusion option.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01521.X

The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01521.X

Residual risk of transfusion-transmitted HCV and HIV infections by antibody-screened blood in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01521.X

Motivations to donate blood: demographic comparisons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01521.X

Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01521.X

[The discarding of blood units and the prevalence of infectious diseases in donors at the Pro-Blood Foundation/Blood Center of São Paulo, São Paulo, Brazil].

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01521.X

Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01521.X

Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01521.X

Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01521.X

Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01521.X

Temporal trends in the prevalence of HIV and other transfusion-transmissible infections among blood donors in northern Thailand, 1990 through 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01521.X

Predictive ability of sequential surveys in determining donor loss from increasingly stringent variant Creutzfeldt-Jakob disease deferral policies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01521.X

10.1111/J.1537-2995.2007.01521.X

21 January 2018

Identifiers

DOI

1 reference

17 April 2018

PubMed ID

18005323

1 reference

17 April 2018